|
Vol. 24 • Na. N1 • February 2022
In this issue:
Exploration of the physical health of dual users of heroin and crack in methadone treatment who inject or have previously injected drugs
Heidebrecht F., Macleod M.B., and Dawkins L.
Patterns of new psychoactive substance use among opioid-dependent patients attending for opioid agonist treatment
McCarron P., Smyth B., Carroll G., Glynn M., Barry J., Whiston L., Keenan E., Darker C., and Truszkowska E.
The Role of Familial and Cultural Factors in Relapse of Methadone Maintenance Treated Patients
Badiei R., Motazedian S., Kheradmand A., and Seif P.
Effects of family functions on opioid use disorder patients to remission
Sahiner I.V., Kir Y., and Sahiner S.
Sexual dysfunction in patients with opioid use disorder: a comparison between naltrexone implant and buprenorphine/naloxone maintenance treatment
Caliskan A.M., and Yildiz M.C.
Characteristics of foreign drug addicts assisted by Addiction Centre in Naples, Italy
Curcio F., Asturaro E., Bandiera F., Barretta V., Fontebasso M., Gautiero G., Rutigliano M.A., Girasole D., Marguccio E., Marsella E., Mazzella C., Nicotra F., Pianese P., Preziuso M., Procida M., Spalice A., Scialò L., and Topa M.
|
|
Vol. 24 • Na. N2 • April 2022
In this issue:
Buprenorphine-Naloxone abuse among Participants in the needle exchange programme. A Finnish Time-Trend Study from 2008 to 2018.
Fältberg N., Partanen M., Lintonen T., Mishina K., and Niemelä S.
Patient Satisfaction with Telemedicine in Addictions
Mayet S., Arshad S., McCaw I., Hashmani Z., Drozdova Z., Gledhill A., Shahbaz S., and Phillips T.
Real-world retention rates with a long-acting buprenorphine depot in opioid-dependent patients attending private clinics in Australia.
MacDonald T., Connor P., Edwards J., Hardy M., Kemp D., and Johnston L.
Relapse rate following institutionalized rehabilitation of male heroin addicts: A Sri Lankan experience
Darshana N., Wijesinghe C., and De Silva V.
Prevalence of Suboptimal Dosing of Methadone and Buprenorphine and Associated Factors in Opioid Dependent Patients
Al-Dewaissan F.B.A.A., Hill D.R., Evans L., and Luz T.C.B.
Exploring impaired insight in opioid addiction: the role of self-stigma
Eidenmueller K., Grimm F., Hermann D., Frischknecht U., Kiefer F., Dziobek I., and Bekier N.K.
|
|
Vol. 24 • Na. N3 • June 2022
In this issue:
Trends in Cigarette Smoking among Italian Substance Use Disorder Patients
Miccoli M., Poli A., Maremmani A.G.I., Della Rocca F., Pani P.P., and Maremmani I.
Results of a survey among opioid addiction treatment providers on the importance of physical exercise
Spitzer U., Meyer M., Guggisberg E., Mirek K., Walter M., and Dursteler K.M.
Baclofen in the Treatment of Alcohol Withdrawal Syndrome in Opioid-Dependent Patients
Gibbons Z., McCarron P., Santlal K., McCarthy R., and Keenan E.
Improving Attendance in Addictions. Do Quality Improvement Plans Work?
Mayet S., Shahbaz S., and Arshad S.
Opium use and risk of stroke: a systematic review and meta-analysis
Borhani-Haghighi A., Tabrizi R., Estakhr M., Hosseini-Bensenjan M., Niknam M., Iravani Saadi M., Moazzen F., and Nowrouzi-Sohrabi P.
Challenges and solutions for opioid dependence therapy during the SARS-CoV-2 pandemic in Germany
Poehlke T.
P300 Event-Related Potentials as a Marker of Craving in Opioid Use Disorder: a Systematic Literature Review
Skrenes A., Labonté L.E., Muñoz-Violant S., Khehra J., Krigolson O., and Schütz C.
|
|
Vol. 24 • Na. N4 • August 2022
In this issue:
Pilot study using long acting injectable buprenorphine (LAIB) as a novel treatment option in NHS Lanarkshire Addiction Services in Scotland
Stewart E., Marr E., and Hill D.
How to Assess Visibility of Drug-Related Stigmatized Behaviours? Does the Choice of Method Matter?
Rastegari A., Haghdoost A., Mehrolhassani M.H., Azizian M., HajiMaghsoudim S., and Baneshi M.R.
Nutritional status of patients in methadone, buprenorphine, and opium tincture maintenance therapy
Kheradmand A., Samani N., and Fazeli A.
Prescription opioids use and opioid-related mortality monitoring in Slovenia
Kostnapfel T., Jandl M., Hočevar Grom A., Korošec A., and Kastelic A.
Quality of life differential changes from psychopathological episodes through recovery in Heroin Addiction
Maremmani A.G.I., Della Rocca F., Bacciardi S., Miccoli M., and Maremmani I.
|
|
Vol. 24 • Na. N5 • October 2022
In this issue:
Quantitative methods in addiction research. The role of the Addiction Research Methods Institute
Miccoli M.
Suboptimal dosing of opioid agonist treatments - a Literature Review
Al-Dewaissan F.B.A.A., Hill D., Evans L., and Luz T.C.B.
Problematic Level of Drug Use and its associated factors among Illicit Drug Users in Sri Lanka: Experience from a Multicentre Study
Darshana N., Wijesinghe C., and De Silva V.
Automated Responses to Opioid-Related Cues as a Dysregulated Allostatic Oxytocin Response: A Short Review
Houghton B.
Hedonic Capacity in Individuals Treated with Medications for Opioid Use Disorder
Wenzel K., Thomas J., Carrano J., Severino A., and Fishman M.
Can the Psychopathology Specific to Substance Use Disorder Distinguish between Recreational Cocaine Use and Cocaine Addiction?
Della Rocca F., Maremmani A.G.I., Bacciardi S., Miccoli M., and Maremmani I.
|
|
Vol. 24 • Na. N6 • December 2022
In this issue:
Impact of opium tincture and exercise in the management of opioid withdrawal: Assessing behavioural and neuroendocrine changes in Opioid Use Disorder patients
Bavisi M., Tirdad R., Ghorbani R., Shafia S., Hajirasouli M., and Miladi-Gorji H.
Reasons behind Use of Heroin and Stimulants: A Functional Perspective
Zhao Q., Hongyu G., and Mao Y.
New insights from Observational Retrospective Study on Tolerability of Levomethadone in Patients with Opioid Use Disorder
Sacco S., Barciocco D., Mussi D., and Bartoletti L.
Opium use and risk of upper gastrointestinal cancers: A systematic review and meta-analysis
Manafi A., Hosseini S., Kashani S.M.A., Owrangi S., Ahmadipour A., Salahi S., and Akbari H.
Image rehearsal therapy as a treatment for nightmares within substance-dependence populations
Flores C., and Riaz U.
Problem Tree Force Field Analysis of injection of opioid agonist therapy and benzodiazepines in North Macedonia
Ignjatova L.A.
|